International Journal of Prostate Cancer
The International Journal of Prostate Cancer serves as the premier forum for publishing breakthrough research in prostate cancer biology including androgen receptor signaling molecular mechanisms tumor microenvironment interactions metastatic progression pathways, early detection strategies evaluating novel biomarkers beyond PSA multiparametric MRI protocols liquid biopsy applications, precision oncology treatments targeting specific molecular subtypes PARP inhibitors AR-targeted therapies immunotherapy approaches radioligand therapy, disease monitoring innovations tracking treatment response assessing minimal residual disease, and patient outcome improvements across surgery radiation systemic therapy advancing our understanding of prostate cancer pathophysiology while improving clinical care survival and quality of life through rigorous peer-reviewed scholarship accessible to urologists medical oncologists radiation oncologists and clinical researchers worldwide.
What You Gain as an Author
Tangible career benefits and research impact when you publish your prostate cancer research
Your Publication Journey
From submission to published article cited in your CV
Why Leading Oncologists Choose Us
See how we compare to traditional subscription journals in prostate cancer research
| Feature | Our Journal | Traditional Journals |
|---|---|---|
| Review Timeline | 6 weeks avg | 14-20 weeks |
| Global Access | Immediate worldwide | Subscription only |
| Citation Impact | 3.1x higher | Baseline |
| Grant Compliance | NIH NCI DOD compliant | Requires payment |
| Author Copyright | Retained by author | Transferred to publisher |
| Download Stats | 2.8x more downloads | Limited readership |
| Supplementary Data | Unlimited genomic datasets | Size restrictions |
Additional Advantages for Prostate Cancer Researchers
Beyond standard databases, we ensure inclusion in prostate cancer-specific registries, NCI clinical trials databases, AUA urology literature collections, ASCO oncology repositories, and NCCN guideline reference systems ensuring your research reaches specialized audiences who will cite and apply your findings in clinical practice and future investigations.
Published authors receive complimentary support creating conference abstracts for AUA ASCO ESMO ASTRO meetings, assistance preparing visually compelling poster presentations, guidance developing oral presentation slides, and early publication timing coordination ensuring your findings appear in peer-reviewed literature before major conference presentations enhancing credibility and media interest.
Our dedicated press team promotes high-impact studies to medical news outlets like MedPage Today Healio OncLive Cancer Network and mainstream media ensuring your research receives attention from clinicians patients advocacy groups and the public. This amplifies author visibility, institutional reputation, and can accelerate clinical implementation of practice-changing findings benefiting patients faster.
We provide authors with comprehensive citation tracking dashboards showing not just citation counts but also geographic distribution of citing authors, clinical vs basic research applications, inclusion in systematic reviews and meta-analyses, mentions in clinical practice guidelines, and social media discussion metrics helping you demonstrate research impact for promotion packets grant applications and institutional reporting requirements.
Professional Benefits
How publishing accelerates your academic oncology career
We Publish Across All Aspects of Prostate Cancer
Comprehensive coverage from basic biology to clinical outcomes
Early Detection
PSA screening strategies, novel biomarkers, multiparametric MRI, liquid biopsies, circulating tumor cells, risk stratification models predicting aggressive disease
Precision Oncology
Genomic profiling, PARP inhibitors, AR-targeted therapies, immunotherapy, radioligand therapy, personalized treatment selection based on molecular subtypes
Surgical Outcomes
Robotic prostatectomy techniques, nerve-sparing procedures, lymph node dissection, continence recovery, erectile function preservation, salvage surgery
Radiation Therapy
IMRT, SBRT, brachytherapy, proton therapy, treatment planning optimization, toxicity reduction, salvage radiation, oligometastatic disease management
Advanced Disease
Castration-resistant prostate cancer, metastatic disease treatment, bone metastases management, novel systemic therapies, clinical trials, survival outcomes
Quality of Life
Patient-reported outcomes, survivorship care, managing treatment side effects, sexual health, urinary function, mental health, supportive care interventions
How Open Access Accelerated Author Careers
Real outcomes from researchers who published their prostate cancer research with us
Published PARP inhibitor resistance mechanisms study. Received 340 citations in 18 months, invited to 8 international conferences, promoted to Associate Professor 2 years ahead of schedule.
PSA screening biomarker research downloaded 12000 times globally. Led to NIH R01 grant award, collaboration invitations from 15 institutions, implemented in 40 cancer centers.
Why Prostate Cancer Researchers Choose Open Access
Comprehensive Author Support Services
Editorial team reviews your manuscript outline before submission, provides journal fit assessment, suggests alternative outlets if needed, estimates review timeline, and identifies potential reviewer concerns enabling proactive manuscript strengthening.
Complimentary biostatistician consultation ensures appropriate methodology for trial design, validates statistical tests selection, reviews power calculations, checks multiple testing corrections, and confirms data presentation clarity preventing statistical review delays.
Professional medical illustrators optimize complex genomic data visualizations, Kaplan-Meier survival curves, forest plots, flow cytometry results, immunohistochemistry images, and radiologic findings ensuring maximum clarity and impact for readers and reviewers.
For time-sensitive findings like novel therapeutic targets, resistance mechanisms, or clinical trial results requiring immediate dissemination, we offer expedited review with first decision in 2 weeks and publication within 4 weeks ensuring rapid knowledge translation.
Investment in Your Research Impact
Select the tier supporting your publication goals
Questions About Publishing?
Our editorial team is ready to assist with your submission
[email protected]Publish Your Prostate Cancer Research
Submit your oncology research for expert peer review and immediate global open access distribution advancing prostate cancer science and improving patient outcomes worldwide.